Compare Citius Pharmaceuticals Inc (CTXR) vs International Business Machines Corp (IBM) Price & Performance

Citius Pharmaceuticals IncTrade

International Business Machines CorpTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs International Business Machines Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while International Business Machines Corp trades at $235.2 (market cap $224.62B). The key difference: International Business Machines Corp is far larger — about 11225.4× Citius Pharmaceuticals Inc's market cap, and International Business Machines Corp pays a 2.84% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

	CTXR	IBM
Market Cap	$20.01M	$224.62B
Sector	Health	Technology
52-Week High	$1.82	$329.23
52-Week Low	$0.48	$205.77
Enterprise Value	$16.23M	$281.76B
Volume	—	4,481,527
Dividend Yield	—	2.84%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

No Aura AI signal available yet.

International Business Machines Corp

IBM trades at $236.31, down 0.41% today, with a mixed technical picture showing bearish moving averages but bullish overall signals. Recent earnings beat expectations in Q4 2025 and Q1 2026, with Q2 2026 meeting estimates, while revenue grew to $67.54 billion in 2025. The company secured a $240 million AI deal with Together AI, boosting sentiment despite ongoing securities fraud investigations.

Outlook: IBM's strong profitability and AI growth present upside potential, but legal risks and high valuation ratios pose challenges. The consensus price target of $257.38 suggests moderate growth, supported by institutional buy ratings, though investors should monitor legal developments and competitive pressures in the tech sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTXR

Citius Oncology appoints Jonathan Peri as new independent board member to strengthen governance.PRNewsWire · 5 hours agoBullish View details →

IBM

Big Tech plans $725B AI spend in 2026, but IBM warns revenue may not justify it.24/7 Wall Street · 1 day agoNeutral IBM and Together AI launch first large-scale NVIDIA HGX B300 AI inference cluster on IBM Cloud.PRNewsWire · 1 day agoBullish OpenAI expands Daybreak cyber defense with new GPT-5.6-Cyber model for advanced security tasksTechCrunch · 1 day agoBullish View details →

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.